Physician
Healthstar Physicians, P.C.
Healthstar Physicians, P.C. was paid $28.05M by Medicaid between Jan 2018 and Dec 2024, across 344 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoHEALTHSTAR PHYSICIANS, P.C.
MORRISTOWN, TN 37813
MORRISTOWN, TN 37813
33aNPI1184610248assigned 09/23/2005
33bProvider typeFamily Medicine Physician
28Total paid$28.05M
24GClaims3,416,265
24DCodes billed344
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Tennessee
Rank by total paid#2 of 754
Median peer was paid$34K
This provider vs. median831×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 216,087 | $3.66M | |
| 2019 | 282,492 | $3.92M | |
| 2020 | 448,740 | $3.65M | |
| 2021 | 634,081 | $4.14M | |
| 2022 | 622,708 | $4.07M | |
| 2023 | 652,704 | $4.62M | |
| 2024incomplete | 559,453 | $4.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 236,931 | 188,360 | $7.13M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 215,322 | 165,563 | $6.73M |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 6.0% | 1,237 | 1,106 | $1.68M |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 2.1% | 6,064 | 5,217 | $589K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.1% | 12,504 | 11,216 | $588K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.9% | 11,372 | 8,835 | $535K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.9% | 11,722 | 9,943 | $522K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.5% | 3,475 | 3,241 | $432K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 13,413 | 11,340 | $366K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 43,181 | 23,500 | $351K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 34,494 | 29,518 | $346K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 4,005 | 3,733 | $313K |
332 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 5,771 | $301K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 28,864 | $294K |
| 95913 | 1.0% | 1,880 | $287K | |
| 95886 | <1% | 3,375 | $254K | |
| 92557 | <1% | 11,573 | $250K | |
| 99243 | <1% | 2,683 | $246K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 53,669 | $231K |
| 95117 | <1% | 32,483 | $228K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,953 | $226K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 3,212 | $215K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 10,738 | $193K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 2,872 | $179K |
| 99245 | <1% | 1,095 | $169K | |
| 11721 | <1% | 34,049 | $168K | |
| 17110 | <1% | 3,669 | $162K | |
| 92567 | <1% | 15,295 | $156K | |
| 59025 | Fetal non-stress test | <1% | 4,194 | $147K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,851 | $140K |
| 11102 | <1% | 3,452 | $138K | |
| 76830 | Ultrasound, transvaginal | <1% | 2,094 | $137K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,640 | $131K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,981 | $131K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14,604 | $128K |
| 99205 | Prolong outpt/office vis | <1% | 1,612 | $114K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 523 | $104K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 989 | $98K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 5,876 | $97K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,043 | $88K |
| 80061 | Lipid panel | <1% | 23,567 | $85K |
| 99307 | <1% | 15,247 | $84K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 72,154 | $81K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 325 | $80K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 811 | $72K |
| 99050 | <1% | 4,507 | $72K | |
| 80050 | General health panel | <1% | 4,570 | $69K |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 2,530 | $69K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,285 | $67K |
| 93922 | <1% | 3,077 | $67K | |
| 77080 | <1% | 3,562 | $59K | |
| 95251 | <1% | 4,683 | $59K | |
| 95923 | <1% | 987 | $56K | |
| 84481 | <1% | 10,539 | $55K | |
| 82607 | <1% | 11,707 | $52K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 9,044 | $49K |
| 73630 | <1% | 4,579 | $47K | |
| 82728 | <1% | 9,705 | $43K | |
| 73120 | <1% | 5,124 | $43K | |
| 80053 | Comprehensive metabolic panel | <1% | 29,816 | $41K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 296 | $40K |
| 85652 | <1% | 13,123 | $38K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18,395 | $37K |
| 99173 | <1% | 6,384 | $36K | |
| 20610 | <1% | 1,792 | $34K | |
| 99304 | <1% | 3,078 | $34K | |
| L1820 | Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 654 | $34K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 645 | $33K |
| 95911 | <1% | 278 | $33K | |
| 31575 | <1% | 1,109 | $32K | |
| 12032 | <1% | 326 | $32K | |
| 92551 | <1% | 3,753 | $31K | |
| 81003 | <1% | 25,239 | $31K | |
| 82565 | <1% | 5,678 | $31K | |
| 93925 | <1% | 708 | $30K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,108 | $30K |
| 84439 | <1% | 12,568 | $30K | |
| 0500F | <1% | 2,592 | $30K | |
| 92587 | <1% | 891 | $30K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,790 | $29K |
| 1160F | <1% | 370,616 | $28K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 2,119 | $28K |
| 99497 | <1% | 2,641 | $28K | |
| 81025 | <1% | 5,178 | $27K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14,939 | $26K |
| 95910 | <1% | 287 | $26K | |
| 82670 | <1% | 2,644 | $25K | |
| 3008F | <1% | 319,449 | $24K | |
| 11100 | <1% | 547 | $24K | |
| 84520 | <1% | 5,714 | $24K | |
| 83735 | <1% | 5,720 | $24K | |
| 87807 | <1% | 2,353 | $23K | |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | <1% | 719 | $23K |
| 83970 | <1% | 2,394 | $23K | |
| 80051 | <1% | 3,255 | $23K | |
| 84403 | <1% | 2,766 | $22K | |
| 95816 | <1% | 183 | $22K | |
| 82962 | <1% | 17,332 | $22K | |
| 59426 | <1% | 45 | $22K | |
| 1159F | <1% | 340,806 | $22K | |
| 72200 | <1% | 2,317 | $21K | |
| 76882 | <1% | 879 | $21K | |
| 73560 | <1% | 2,214 | $21K | |
| 11056 | <1% | 5,494 | $20K | |
| 87428 | <1% | 381 | $20K | |
| 92555 | <1% | 1,395 | $19K | |
| 99242 | <1% | 269 | $19K | |
| 99483 | Prolong outpt/office vis | <1% | 237 | $18K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 673 | $18K |
| 54150 | <1% | 110 | $17K | |
| 99401 | <1% | 2,372 | $17K | |
| 11103 | <1% | 383 | $17K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 652 | $16K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 129 | $16K |
| 0503F | <1% | 889 | $16K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 3,027 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 6,266 | $15K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 648 | $15K |
| 3074F | <1% | 228,889 | $14K | |
| 96127 | <1% | 3,599 | $14K | |
| 82947 | <1% | 3,032 | $14K | |
| 76536 | <1% | 514 | $14K | |
| 3078F | <1% | 210,246 | $13K | |
| 96101 | <1% | 361 | $13K | |
| 62323 | <1% | 190 | $12K | |
| 59425 | <1% | 35 | $12K | |
| 99442 | <1% | 1,241 | $12K | |
| 90686 | <1% | 3,710 | $12K | |
| 17000 | <1% | 1,697 | $12K | |
| 95811 | <1% | 149 | $11K | |
| 59410 | <1% | 14 | $11K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 546 | $11K |
| 96132 | <1% | 326 | $11K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,001 | $11K |
| 90674 | <1% | 1,355 | $11K | |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | <1% | 1,216 | $11K |
| 98929 | <1% | 204 | $11K | |
| 36416 | <1% | 15,179 | $10K | |
| 1126F | <1% | 91,875 | $10K | |
| 86141 | <1% | 2,813 | $10K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 350 | $10K |
| 84466 | <1% | 3,124 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,043 | $10K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 4,083 | $10K |
| 11750 | <1% | 79 | $9K | |
| 84146 | <1% | 1,607 | $9K | |
| 81002 | <1% | 3,812 | $9K | |
| 82550 | <1% | 2,316 | $9K | |
| 96161 | <1% | 564 | $9K | |
| 86160 | <1% | 2,032 | $9K | |
| J1000 | Injection, depo-estradiol cypionate, up to 5 mg | <1% | 718 | $8K |
| 95250 | <1% | 455 | $8K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 2,038 | $8K |
| 82043 | <1% | 5,596 | $8K | |
| 95909 | <1% | 119 | $8K | |
| 95024 | <1% | 85 | $8K | |
| 1125F | <1% | 95,672 | $8K | |
| 11755 | <1% | 670 | $8K | |
| 92504 | <1% | 362 | $8K | |
| 99490 | Ccm add 20min | <1% | 4,009 | $8K |
| 11057 | <1% | 1,453 | $8K | |
| 83540 | <1% | 3,834 | $7K | |
| 90688 | <1% | 1,408 | $7K | |
| 3079F | <1% | 80,036 | $7K | |
| 80076 | <1% | 3,334 | $7K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 3,561 | $7K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,588 | $7K |
| 86431 | <1% | 3,713 | $7K | |
| A5514 | For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each | <1% | 352 | $6K |
| 64615 | <1% | 60 | $6K | |
| 90715 | <1% | 197 | $6K | |
| 17003 | <1% | 864 | $6K | |
| 69210 | <1% | 212 | $6K | |
| 86140 | <1% | 3,931 | $6K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 415 | $5K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 678 | $5K |
| 83550 | <1% | 2,206 | $5K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 7,088 | $5K |
| 82746 | <1% | 913 | $5K | |
| 82533 | <1% | 903 | $5K | |
| 94010 | <1% | 363 | $5K | |
| 96160 | <1% | 453 | $5K | |
| 64493 | <1% | 165 | $5K | |
| G0008 | Administration of influenza virus vaccine | <1% | 3,587 | $4K |
| L4360 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 49 | $4K |
| 64483 | <1% | 66 | $4K | |
| 20550 | <1% | 150 | $4K | |
| A5512 | For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each | <1% | 641 | $4K |
| 84550 | <1% | 2,876 | $4K | |
| 59430 | <1% | 314 | $4K | |
| 95115 | <1% | 872 | $4K | |
| 96130 | <1% | 256 | $4K | |
| 99441 | <1% | 549 | $4K | |
| 82570 | <1% | 2,303 | $3K | |
| 90756 | <1% | 862 | $3K | |
| 80306 | <1% | 205 | $3K | |
| 82950 | <1% | 667 | $3K | |
| 90461 | <1% | 5,850 | $3K | |
| 3077F | <1% | 30,936 | $3K | |
| 93970 | <1% | 52 | $3K | |
| 62321 | <1% | 30 | $3K | |
| 99334 | <1% | 164 | $3K | |
| 84144 | <1% | 183 | $3K | |
| 83525 | <1% | 490 | $3K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 867 | $3K |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 1,319 | $3K |
| 96138 | <1% | 344 | $3K | |
| 73562 | <1% | 303 | $3K | |
| 3075F | <1% | 31,779 | $2K | |
| 90670 | <1% | 1,964 | $2K | |
| 99385 | <1% | 35 | $2K | |
| 72114 | <1% | 529 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,903 | $2K |
| 99402 | <1% | 49 | $2K | |
| 99439 | <1% | 1,019 | $2K | |
| 31231 | <1% | 17 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,590 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,659 | $2K |
| 0011A | <1% | 67 | $2K | |
| 99406 | <1% | 641 | $2K | |
| 82951 | <1% | 201 | $2K | |
| 82310 | <1% | 384 | $2K | |
| 17311 | <1% | 17 | $2K | |
| 99459 | <1% | 105 | $2K | |
| 84681 | <1% | 397 | $2K | |
| 90837 | Psychotherapy session, about an hour | <1% | 95 | $2K |
| 99305 | <1% | 104 | $2K | |
| 90661 | <1% | 317 | $1K | |
| 0012A | <1% | 52 | $1K | |
| 76881 | <1% | 87 | $1K | |
| 3080F | <1% | 8,364 | $1K | |
| 95922 | <1% | 45 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 42 | $1K |
| 99443 | <1% | 103 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,059 | $1K |
| 0031A | <1% | 49 | $1K | |
| 11055 | <1% | 263 | $1K | |
| 99358 | Prolong nursin fac eval 15m | <1% | 21 | $1K |
| 96131 | <1% | 67 | $1K | |
| 81001 | <1% | 1,465 | $1K | |
| 85018 | <1% | 405 | $1K | |
| 59200 | <1% | 19 | $950.75 | |
| 64494 | <1% | 91 | $935.19 | |
| 96136 | <1% | 127 | $882.47 | |
| 99324 | <1% | 73 | $819.09 | |
| 90656 | <1% | 311 | $770.40 | |
| 83655 | <1% | 74 | $764.44 | |
| 90653 | <1% | 112 | $741.28 | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | <1% | 152 | $717.08 |
| 11403 | <1% | 13 | $690.05 | |
| 99397 | <1% | 465 | $686.62 | |
| 90716 | <1% | 323 | $659.56 | |
| 95806 | <1% | 14 | $651.84 | |
| 90723 | <1% | 1,049 | $649.26 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 297 | $639.56 |
| A5513 | For diabetics only, multiple density insert, custom molded from model of patient's foot, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each | <1% | 52 | $626.48 |
| 84100 | <1% | 571 | $604.59 | |
| 81000 | <1% | 786 | $579.19 | |
| 71250 | <1% | 24 | $568.45 | |
| 97597 | <1% | 101 | $545.97 | |
| 90651 | <1% | 111 | $540.00 | |
| 87220 | <1% | 195 | $537.38 | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 449 | $505.24 |
| 99201 | <1% | 18 | $492.69 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 62 | $446.28 |
| 94060 | <1% | 15 | $443.71 | |
| 11101 | <1% | 16 | $441.47 | |
| 51798 | <1% | 102 | $417.80 | |
| 94729 | <1% | 15 | $403.92 | |
| 94726 | <1% | 15 | $401.13 | |
| J1380 | Injection, estradiol valerate, up to 10 mg | <1% | 83 | $400.25 |
| 0134A | <1% | 34 | $313.10 | |
| 82652 | <1% | 17 | $304.80 | |
| 97760 | <1% | 23 | $289.02 | |
| 92552 | <1% | 13 | $283.82 | |
| 84432 | <1% | 17 | $280.28 | |
| 90707 | <1% | 300 | $267.31 | |
| 95976 | <1% | 21 | $266.81 | |
| 90671 | <1% | 339 | $265.63 | |
| 90677 | <1% | 133 | $260.05 | |
| 95249 | <1% | 26 | $259.71 | |
| 87210 | <1% | 66 | $254.48 | |
| 11720 | <1% | 72 | $243.78 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $236.62 |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 50 | $236.40 |
| 20611 | <1% | 24 | $221.73 | |
| 90680 | <1% | 670 | $220.62 | |
| 86800 | <1% | 16 | $211.30 | |
| 73610 | <1% | 32 | $161.26 | |
| 90672 | <1% | 131 | $158.53 | |
| 90658 | <1% | 15 | $132.09 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 14 | $129.82 |
| 72052 | <1% | 24 | $120.62 | |
| 92228 | <1% | 23 | $107.53 | |
| 94760 | <1% | 785 | $95.12 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 43 | $90.00 |
| 90633 | <1% | 262 | $87.66 | |
| 90648 | <1% | 1,192 | $65.52 | |
| 90696 | <1% | 46 | $57.98 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 18 | $50.82 |
| Q2039 | Influenza virus vaccine, not otherwise specified | <1% | 20 | $40.24 |
| 1170F | <1% | 3,186 | $40.01 | |
| 90647 | <1% | 657 | $34.35 | |
| 90660 | <1% | 15 | $31.15 | |
| 99499 | <1% | 17,812 | $25.05 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 19 | $23.77 |
| J2010 | Injection, lincomycin hcl, up to 300 mg | <1% | 18 | $21.98 |
| 0502F | <1% | 32,764 | $20.00 | |
| 80305 | <1% | 14 | $17.96 | |
| 99000 | <1% | 7,070 | $11.84 | |
| 3044F | <1% | 6,493 | $10.05 | |
| 3046F | <1% | 932 | $10.00 | |
| 99072 | <1% | 504 | $4.29 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $1.41 |
| 3288F | <1% | 3,631 | $0.04 | |
| 1036F | <1% | 57,098 | $0.03 | |
| G8476 | Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg | <1% | 5,847 | $0.03 |
| 3061F | <1% | 2,415 | $0.02 | |
| 4040F | <1% | 6,720 | $0.01 | |
| 1158F | <1% | 1,462 | $0.01 | |
| 3754F | 0% | 571 | $0.00 | |
| 99024 | 0% | 4,903 | $0.00 | |
| 3060F | 0% | 540 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 831 | $0.00 |
| 0501F | 0% | 1,266 | $0.00 | |
| 97010 | 0% | 234 | $0.00 | |
| 3294F | 0% | 240 | $0.00 | |
| 3292F | 0% | 1,092 | $0.00 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 0% | 116 | $0.00 |
| 90694 | 0% | 45 | $0.00 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 336 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 125 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 194 | $0.00 |
| 3052F | 0% | 240 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 5,472 | $0.00 |
| 4004F | 0% | 6,748 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 170 | $0.00 |
| 90685 | 0% | 80 | $0.00 | |
| 3051F | 0% | 415 | $0.00 | |
| 90700 | 0% | 13 | $0.00 | |
| 90734 | 0% | 71 | $0.00 | |
| 3045F | 0% | 143 | $0.00 | |
| 90687 | 0% | 31 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRABSON, ODESSA (CHIEF EXECUTIVE OFFICER)